SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology reseach unit specializing in complex early-phase trials, announced today the successful completion of a validation study of the NeuroCart. The study validated the NeuroCart as an effective tool for detectin of benzodiazepine-evoked pharmacodynamic CNS effect.